Correlation Between Esperion Therapeutics and MYR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and MYR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and MYR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and MYR Group, you can compare the effects of market volatilities on Esperion Therapeutics and MYR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of MYR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and MYR.

Diversification Opportunities for Esperion Therapeutics and MYR

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Esperion and MYR is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and MYR Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MYR Group and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with MYR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MYR Group has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and MYR go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and MYR

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 1.99 times more return on investment than MYR. However, Esperion Therapeutics is 1.99 times more volatile than MYR Group. It trades about 0.09 of its potential returns per unit of risk. MYR Group is currently generating about 0.04 per unit of risk. If you would invest  91.00  in Esperion Therapeutics on August 29, 2024 and sell it today you would earn a total of  163.00  from holding Esperion Therapeutics or generate 179.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Esperion Therapeutics  vs.  MYR Group

 Performance 
       Timeline  
Esperion Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
MYR Group 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in MYR Group are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, MYR reported solid returns over the last few months and may actually be approaching a breakup point.

Esperion Therapeutics and MYR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Esperion Therapeutics and MYR

The main advantage of trading using opposite Esperion Therapeutics and MYR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, MYR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MYR will offset losses from the drop in MYR's long position.
The idea behind Esperion Therapeutics and MYR Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments